Terrence Chew
Corporate Officer/Principal bei ImmuneWorks, Inc.
Profil
Terrence Chew is currently the Head-Clinical & Regulatory Development at ImmuneWorks, Inc. He previously worked as the Director-Medical Research at Agouron Pharmaceuticals LLC, Principal at Johnson & Johnson, Vice President-Regulatory & Clinical Affairs at Avid Bioservices, Inc., and Vice President-Clinical Development at DepoTech Corp.
He also served as the Chief Medical Officer at Prescient Therapeutics Ltd.
from 2015 to 2020.
Dr. Chew holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Terrence Chew
| Unternehmen | Position | Beginn |
|---|---|---|
ImmuneWorks, Inc.
 ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Terrence Chew
| Unternehmen | Position | Ende |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
DepoTech Corp.
 DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| AVID BIOSERVICES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Terrence Chew
| University of California, Berkeley | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Health Technology |
DepoTech Corp.
DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Health Technology |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
